975 related articles for article (PubMed ID: 15655736)
21. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920
[TBL] [Abstract][Full Text] [Related]
22. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
[TBL] [Abstract][Full Text] [Related]
23. CD26 expression in leprosy and other granulomatous diseases correlates with the production of interferon-gamma.
Scheel-Toellner D; Richter E; Toellner KM; Reiling N; Wacker HH; Flad HD; Gerdes J
Lab Invest; 1995 Nov; 73(5):685-90. PubMed ID: 7474942
[TBL] [Abstract][Full Text] [Related]
24. Study of cytokine response against panel of purified Mycobacterium leprae antigens by using whole blood assay in subjects residing in a resettlement village of cured leprosy patients.
Kamble RR; Shinde VS; Madhale SP; Jadhav RS
Indian J Lepr; 2010; 82(1):23-31. PubMed ID: 21229844
[TBL] [Abstract][Full Text] [Related]
25. Development of giant reaction in response to PPD skin test in lepromatous leprosy patients.
Sampaio EP; Duppre NC; Nery JA; Moreira AL; Sarno EN
Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):205-13. PubMed ID: 8371029
[TBL] [Abstract][Full Text] [Related]
26. Is PGL-1 also present in Leishmania donovani promastigotes?
Gupta PN; Pal NK
Indian J Lepr; 1998; 70(2):161-4. PubMed ID: 9724851
[TBL] [Abstract][Full Text] [Related]
27. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.
Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR
Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780
[TBL] [Abstract][Full Text] [Related]
28. Immunological cytokine correlates of protective immunity and pathogenesis in leprosy.
Lima MC; Pereira GM; Rumjanek FD; Gomes HM; Duppre N; Sampaio EP; Alvim IM; Nery JA; Sarno EN; Pessolani MC
Scand J Immunol; 2000 Apr; 51(4):419-28. PubMed ID: 10736116
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions.
Da-Cruz AM; Bertho AL; Oliveira-Neto MP; Coutinho SG
Br J Dermatol; 2005 Sep; 153(3):537-43. PubMed ID: 16120139
[TBL] [Abstract][Full Text] [Related]
30. Elevated serum CCL2 concomitant with a reduced mycobacterium-induced response leads to disease dissemination in leprosy.
Hasan Z; Jamil B; Zaidi I; Zafar S; Khan AA; Hussain R
Scand J Immunol; 2006 Mar; 63(3):241-7. PubMed ID: 16499578
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa.
Bobosha K; Van Der Ploeg-Van Schip JJ; Zewdie M; Sapkota BR; Hagge DA; Franken KL; Inbiale W; Aseffa A; Ottenhoff TH; Geluk A
Lepr Rev; 2011 Dec; 82(4):445-58. PubMed ID: 22439283
[TBL] [Abstract][Full Text] [Related]
32. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
[TBL] [Abstract][Full Text] [Related]
33. Cytokines in mycobacterial infections: in vitro and ex vivo studies.
Flad HD; Gercken J; Hübner L; Schlüter C; Pryjma J; Ernst M
Arch Immunol Ther Exp (Warsz); 1995; 43(2):153-8. PubMed ID: 8744732
[TBL] [Abstract][Full Text] [Related]
34. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy.
Sieling PA; Abrams JS; Yamamura M; Salgame P; Bloom BR; Rea TH; Modlin RL
J Immunol; 1993 Jun; 150(12):5501-10. PubMed ID: 8515073
[TBL] [Abstract][Full Text] [Related]
35. Leishmanial amastigote antigen P-2 induces major histocompatibility complex class II-dependent natural killer-cell reactivity in cells from healthy donors.
Nylén S; Maasho K; McMahon-Pratt D; Akuffo H
Scand J Immunol; 2004 Mar; 59(3):294-304. PubMed ID: 15030581
[TBL] [Abstract][Full Text] [Related]
36. Cell mediated immunity in American cutaneous and mucosal leishmaniasis.
Carvalho EM; Johnson WD; Barreto E; Marsden PD; Costa JL; Reed S; Rocha H
J Immunol; 1985 Dec; 135(6):4144-8. PubMed ID: 4067312
[TBL] [Abstract][Full Text] [Related]
37. In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions.
Longley J; Haregewoin A; Yemaneberhan T; Warndorff van Diepen T; Nsibami J; Knowles D; Smith KA; Godal T
Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):385-94. PubMed ID: 3900245
[TBL] [Abstract][Full Text] [Related]
38. Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients.
Chattree V; Khanna N; Rao DN
Mol Immunol; 2007 Mar; 44(8):2066-77. PubMed ID: 17046060
[TBL] [Abstract][Full Text] [Related]
39. Antigenic protein from Mycobacterium leprae released in macrophages in vitro as indicator of viability of bacteria.
Nair I; Mahadevan PR
Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):540-7. PubMed ID: 2205688
[TBL] [Abstract][Full Text] [Related]
40. M. leprae- and BCG-induced chemiluminescence response of monocytes from leprosy patients and healthy subjects: effects of gamma-interferon and GM-CSF.
Launois P; Blum L; Dieye A; Millan J; Sarthou JL; Michel JC; Bach MA
Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):582-9. PubMed ID: 1802941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
